SCHEMBL19079735

SCHEMBL19079735

O=C(CSc1nc2sc3c(c2c(=O)n1C1CC1)CCOC3)c1cccs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 4/20 0.56
▸ ALDH1A1 P00352 7/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ LMNA P02545 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ TSHR P16473 4/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ USP2 O75604 1/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ NPSR1 Q6W5P4 5/20 0.44
▸ MAPT P10636 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ TP53 P04637 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ CREBBP Q92793 2/20 0.41
▸ TGM2 P21980 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079754 0.88 PDE4D (0.71) PDE4DALDH1A1HPGDMEN1KMT2A
SCHEMBL19079738 0.86 PDE4D (0.57) PDE4DALDH1A1HPGDMEN1KMT2A
SCHEMBL19079737 0.85 PDE4D (0.56) PDE4DALDH1A1HPGDMEN1KMT2A
SCHEMBL19079829 0.83 PDE4D (0.79) PDE4DALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL19079756 0.82 PDE4D (0.53) PDE4DALDH1A1HPGDMEN1KMT2A
SCHEMBL19079825 0.80 CREBBP (0.63) ALDH1A1HPGDMEN1KMT2AHIF1A
SCHEMBL19079694 0.76 PDE4D (0.76) PDE4DALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL19079720 0.75 PDE4D (0.77) PDE4DALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL19079736 0.74 PDE4D (0.68) PDE4DALDH1A1HPGDMEN1KMT2A
SCHEMBL19079728 0.74 PDE4D (0.76) PDE4DALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885ALDH1A1 1503/4885HPGD 544/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885ALDH1A1 1503/4885HPGD 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback